Episode 26 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused Strategies to Improve Outcomes - Part 2: Treatment of Non-Frail Patients With NDMM

In this podcast series, Dr. Orlowski, Dr. Raje, and Dr. Voorhees inform and guide participants on latest developments from clinical trials on quadruplet and triplet regimens, based on updates from the European Hematology Association (EHA) 2024 meeting. Using clinical case scenarios, they’ll clarify clinical endpoints and outcomes to enable safe and effective frontline regimen choices among diverse patients with newly diagnosed multiple myeloma (NDMM) who have distinct needs. Listen to the available episodes as experts lay the foundation for optimal first-line, maintenance, transplantation, and subsequent therapy choice based on the risk profile of patients, to ultimately improve outcomes in multiple myeloma (MM). Launch Date: July 19, 2024 Release Date: June 26, 2024 Expiration Date: June 30, 2025 FACULTY Robert Orlowski, MD, PhD Professor of Medicine Director, Section of Myeloma The University of Texas, MD Anderson Cancer Center Noopur Raje, MD Director, Center for Multiple Myeloma Massachusetts General Hospital Peter Voorhees, MD Chief, Plasma Cell Disorders Division Atrium Health / Levine Cancer Institute Clinical Professor of Medicine Wake Forest University School of Medicine This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided at this link below prior to listening to this podcast. https://www.practicepointcme.com/CMEHome/integrating-quadruplet-regimens-in-newly-diagnosed-multiple-myeloma-patient-focused-strategies-to-improve-outcomes-43